Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3412 | 1593 | 29.8 | 64% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
213 | 3 | BURNS//CRITICAL CARE MEDICINE//SEPSIS | 51408 |
3412 | 2 | PENTOXIFYLLINE//PROPENTOFYLLINE//BUFLOMEDIL | 1593 |
8882 | 1 | PENTOXIFYLLINE//LISOFYLLINE//HEMORRHEOLOGIC AGENTS | 1208 |
29608 | 1 | BUFLOMEDIL//PYRROLIDINES THERAPEUTIC USE//CAS 55837 25 7 | 183 |
31754 | 1 | PROPENTOFYLLINE//HYDROXYPROPENTOFYLLINE//MEDULLARY VISCERAL ZONE | 148 |
37587 | 1 | IBUDILAST//CAS 50847 11 5//3 ISOBUTYRYL 2 ISOPROPYLPYRAZOLO1 5 APYRIDINE PHARMACOLOGY | 54 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PENTOXIFYLLINE | authKW | 2219046 | 23% | 31% | 372 |
2 | PROPENTOFYLLINE | authKW | 569482 | 3% | 57% | 52 |
3 | BUFLOMEDIL | authKW | 349297 | 2% | 68% | 27 |
4 | IBUDILAST | authKW | 254028 | 2% | 51% | 26 |
5 | LISOFYLLINE | authKW | 154005 | 1% | 54% | 15 |
6 | PYRROLIDINES THERAPEUTIC USE | authKW | 57500 | 0% | 100% | 3 |
7 | HEMORRHEOLOGIC AGENTS | authKW | 43124 | 0% | 75% | 3 |
8 | GUDE | address | 40824 | 0% | 30% | 7 |
9 | CAS 55837 25 7 | authKW | 38334 | 0% | 100% | 2 |
10 | CENTROPHENOXINE HYDROCHLORIDE | authKW | 38334 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 2489 | 25% | 0% | 393 |
2 | Peripheral Vascular Diseases | 1365 | 9% | 0% | 147 |
3 | Critical Care Medicine | 670 | 4% | 0% | 69 |
4 | Medicine, Research & Experimental | 606 | 8% | 0% | 133 |
5 | Immunology | 408 | 9% | 0% | 150 |
6 | Hematology | 385 | 6% | 0% | 88 |
7 | Medicine, General & Internal | 258 | 8% | 0% | 120 |
8 | Transplantation | 230 | 3% | 0% | 46 |
9 | Surgery | 222 | 9% | 0% | 136 |
10 | Urology & Nephrology | 170 | 4% | 0% | 60 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GUDE | 40824 | 0% | 30% | 7 |
2 | GEN VASC SURG TRANSPLANTOL | 34498 | 0% | 60% | 3 |
3 | ABT NICHT INVAS DIAGNOST | 19167 | 0% | 100% | 1 |
4 | ABT PHARMAKOL NAT WISSEN | 19167 | 0% | 100% | 1 |
5 | ANIM SCI MOLEC IMMUNOL | 19167 | 0% | 100% | 1 |
6 | BIOPHYSIOL PHARMACOL | 19167 | 0% | 100% | 1 |
7 | BRAIN BEHAV DISCOVERY CL 3020 | 19167 | 0% | 100% | 1 |
8 | CARDIOVASC THORAX SURG | 19167 | 0% | 100% | 1 |
9 | CARMEN FREIRE COBO | 19167 | 0% | 100% | 1 |
10 | CNS PROD GRP | 19167 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | RICERCA IN CLINICA E IN LABORATORIO | 30121 | 2% | 6% | 28 |
2 | ANGIOLOGY | 14025 | 4% | 1% | 58 |
3 | PHARMATHERAPEUTICA | 13662 | 1% | 5% | 15 |
4 | CLINICAL HEMORHEOLOGY | 10561 | 1% | 2% | 23 |
5 | JOURNAL OF MEDICINE | 10187 | 1% | 3% | 17 |
6 | VASA-JOURNAL OF VASCULAR DISEASES | 3604 | 1% | 1% | 19 |
7 | INVESTIGACION MEDICA INTERNACIONAL | 3438 | 0% | 4% | 4 |
8 | CIRCULATORY SHOCK | 3161 | 1% | 1% | 14 |
9 | JOURNAL OF CARDIOVASCULAR MEDICINE-US | 2128 | 0% | 11% | 1 |
10 | IMMUNOPHARMACOLOGY | 2055 | 1% | 1% | 12 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PENTOXIFYLLINE | 2219046 | 23% | 31% | 372 | Search PENTOXIFYLLINE | Search PENTOXIFYLLINE |
2 | PROPENTOFYLLINE | 569482 | 3% | 57% | 52 | Search PROPENTOFYLLINE | Search PROPENTOFYLLINE |
3 | BUFLOMEDIL | 349297 | 2% | 68% | 27 | Search BUFLOMEDIL | Search BUFLOMEDIL |
4 | IBUDILAST | 254028 | 2% | 51% | 26 | Search IBUDILAST | Search IBUDILAST |
5 | LISOFYLLINE | 154005 | 1% | 54% | 15 | Search LISOFYLLINE | Search LISOFYLLINE |
6 | PYRROLIDINES THERAPEUTIC USE | 57500 | 0% | 100% | 3 | Search PYRROLIDINES+THERAPEUTIC+USE | Search PYRROLIDINES+THERAPEUTIC+USE |
7 | HEMORRHEOLOGIC AGENTS | 43124 | 0% | 75% | 3 | Search HEMORRHEOLOGIC+AGENTS | Search HEMORRHEOLOGIC+AGENTS |
8 | CAS 55837 25 7 | 38334 | 0% | 100% | 2 | Search CAS+55837+25+7 | Search CAS+55837+25+7 |
9 | CENTROPHENOXINE HYDROCHLORIDE | 38334 | 0% | 100% | 2 | Search CENTROPHENOXINE+HYDROCHLORIDE | Search CENTROPHENOXINE+HYDROCHLORIDE |
10 | CTP 499 | 38334 | 0% | 100% | 2 | Search CTP+499 | Search CTP+499 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SCHEFFLER, A , DRIESSEN, G , (1998) EXPERIMENTAL EFFECTS OF VASOACTIVE DRUGS FROM THE PHYSIOPATHOLOGICAL POINT OF VIEW.VASA-JOURNAL OF VASCULAR DISEASES. VOL. . ISSUE . P. 43 -60 | 156 | 61% | 0 |
2 | WARD, A , CLISSOLD, SP , (1987) PENTOXIFYLLINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND ITS THERAPEUTIC EFFICACY.DRUGS. VOL. 34. ISSUE 1. P. 50-97 | 97 | 77% | 624 |
3 | LEPORINI, C , PISANO, A , RUSSO, E , D'ARRIGO, G , DE SARRO, G , COPPOLINO, G , BOLIGNANO, D , (2016) EFFECT OF PENTOXIFYLLINE ON RENAL OUTCOMES IN CHRONIC KIDNEY DISEASE PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS.PHARMACOLOGICAL RESEARCH. VOL. 107. ISSUE . P. 315 -332 | 30 | 81% | 1 |
4 | SAMLASKA, CP , WINFIELD, EA , (1994) PENTOXIFYLLINE.JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. VOL. 30. ISSUE 4. P. 603-621 | 72 | 55% | 175 |
5 | CLISSOLD, SP , LYNCH, S , SORKIN, EM , (1987) BUFLOMEDIL - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN PERIPHERAL AND CEREBRAL VASCULAR DISEASES.DRUGS. VOL. 33. ISSUE 5. P. 430-460 | 53 | 95% | 76 |
6 | GROESDONK, HV , HERINGLAKE, M , HEINZE, H , (2009) ANTI-INFLAMMATORY EFFECTS OF PENTOXIFYLLINE IMPORTANCE IN CARDIAC SURGERY.ANAESTHESIST. VOL. 58. ISSUE 11. P. 1136 -+ | 36 | 63% | 1 |
7 | BADRI, S , DASHTI-KHAVIDAKI, S , LESSAN-PEZESHKI, M , ABDOLLAHI, M , (2011) A REVIEW OF THE POTENTIAL BENEFITS OF PENTOXIFYLLINE IN DIABETIC AND NON-DIABETIC PROTEINURIA.JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES. VOL. 14. ISSUE 1. P. 128-137 | 31 | 66% | 12 |
8 | FRAMPTON, JE , BROGDEN, RN , (1995) PENTOXIFYLLINE (OXPENTIFYLLINE) - A REVIEW OF ITS THERAPEUTIC EFFICACY IN THE MANAGEMENT OF PERIPHERAL VASCULAR AND CEREBROVASCULAR DISORDERS.DRUGS & AGING. VOL. 7. ISSUE 6. P. 480-503 | 54 | 59% | 56 |
9 | NASIRI-TOOSI, Z , DASHTI-KHAVIDAKI, S , KHALILI, H , LESSAN-PEZESHKI, M , (2013) A REVIEW OF THE POTENTIAL PROTECTIVE EFFECTS OF PENTOXIFYLLINE AGAINST DRUG-INDUCED NEPHROTOXICITY.EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 69. ISSUE 5. P. 1057-1073 | 34 | 52% | 12 |
10 | VLASE, L , KISS, B , MUNTEAN, D , LEUCUTA, SE , (2010) RAPID HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY METHOD FOR DETERMINATION OF PENTOXIFYLLINE AND ITS ACTIVE METABOLITES M1 AND M5 IN HUMAN PLASMA AND ITS APPLICATION IN BIOAVAILABILITY STUDY.TALANTA. VOL. 82. ISSUE 3. P. 945-951 | 23 | 85% | 6 |
Classes with closest relation at Level 2 |